Drug interactions between Incruse Ellipta and Spiriva
|Incruse Ellipta (umeclidinium)|
Interactions between your drugs
tiotropium ↔ umeclidinium
Applies to:Spiriva (tiotropium) and Incruse Ellipta (umeclidinium)
Talk to your doctor before using tiotropium together with umeclidinium. Although side effects are generally uncommon with inhaled preparations because very little of the medication gets absorbed into the bloodstream from the lungs, they can occur occasionally (especially in the elderly), and the risk may be increased when used with other medications. Some of the side effects include drowsiness, blurred vision, dry mouth, heat intolerance, flushing, decreased sweating, difficulty urinating, abdominal cramping, constipation, rapid heart beat, confusion, memory problems, and glaucoma. You should keep your eyes closed when using an inhaled product to keep the medication from getting into the eye. Avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medications affect you. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
The recommended maximum number of medicines in the 'anticholinergics/antispasmodics' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'anticholinergics/antispasmodics' category:
- umeclidinium (active ingredient in Incruse Ellipta (umeclidinium))
- tiotropium (active ingredient in Spiriva (tiotropium))
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.